NCT01178151View on ClinicalTrials.gov

Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Peutz-Jeghers SyndromeNeoplastic ProcessesNeoplasm Metastasis
Interventions
DRUG

Everolimus

10mg daily orally

Trial Locations (2)

1105AZ

Academic Medical Center, Amsterdam

3000 CA

Erasmus Medical Center, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER